Home / 510(k) Clearances / K251668

510(k) K251668

SurfRider 13 Microcatheter by Kaneka Americas Holding, Inc. — Product Code QJP

K251668 is an FDA 510(k) premarket notification submitted by Kaneka Americas Holding, Inc. for the device "SurfRider 13 Microcatheter". The FDA issued a decision of Substantially Equivalent on January 5, 2026. The device falls under product code QJP (Catheter, Percutaneous, Neurovasculature), a Class II device regulated under 21 CFR 870.1250.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 5, 2026
Date Received
May 30, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Catheter, Percutaneous, Neurovasculature
Device Class
Class II
Regulation Number
870.1250
Review Panel
NE
Submission Type

To provide vascular access to the neurovasculature for interventional or diagnostic procedures

Other clearances for product code QJP

  • K260199 — SLIM Microcatheter (July 13, 2026)
  • K253901 — Millipede88 Access Catheter (July 9, 2026)
  • K261889 — Trevo Trak 21 Microcatheter (July 1, 2026)
  • K261808 — ISAAC Neurovascular Navigation Catheter (June 30, 2026)
  • K261549 — BOBBY Balloon Guide Catheter (June 9, 2026)
  • K253359 — Zenith Distal Access Long Sheath (May 22, 2026)
  • K254178 — SAYA 86 Radial Access Guide Catheter (May 11, 2026)
  • K254046 — BosCATH Support Catheter (April 21, 2026)
  • K254223 — Next Generation 088 Catheter (April 16, 2026)
  • K260938 — PATH BGC (April 15, 2026)

FDA data resources